Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 242 clinical trials
featured
C3421005 T2DM  

A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

  • 9970 views
  • 18 Jan, 2021
  • 40 locations
featured
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

chemoradiotherapy
non-small cell carcinoma
  • 90 views
  • 23 Nov, 2020
  • 1 location
featured
Are you a type 2 diabetic between 30 and 70 years of age and currently being treated with either Metformin alone or Metformin in combination with Sulfonylurea such as Glyburide (Diabeta), Glipizide (Glucotrol), Repaglinide (Prandin)?

Are you a type 2 diabetic between 30 and 70 years of age and currently being treated with either Metformin alone or Metformin in combination with Sulfonylurea such as Glyburide (Diabeta), Glipizide

  • 94 views
  • 08 Nov, 2020
  • 1 location
featured
NN2211-4232 LIRA-PRIME: Efficacy in controlling glycaemia with Victoza (liraglutide) as add-on to metformin vs. OAD's as add-on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes inadequately controlled with metformin monotherapy and treated in a primary care setting.

NN2211-4232 LIRA-PRIME: Efficacy in controlling glycaemia with Victoza (liraglutide) as add-on to metformin vs. OAD's as add-on to metformin after up to 104 weeks of treatment in subjects with type 2

  • 484 views
  • 23 Nov, 2020
  • 1 location
featured
The study will examine the effects that Metformin Hydrochloride has on Prostate Specific Antigen levels in men with Prostate Cancer.

The study will examine the effects that Metformin Hydrochloride has on Prostate Specific Antigen levels in men with Prostate Cancer.

  • 70 views
  • 23 Nov, 2020
  • 1 location
featured
A randomized, 30-week, active-controlled, open label, 2-treatment arm, parallel-group, multicenter study comparing the efficacy and safety of the insulin glargine/lixisenatide fixed ratio combination to insulin glargine with or without metformin in patients with T2DM.

to insulin glargine with or without metformin in patients with T2DM.

  • 68 views
  • 23 Nov, 2020
  • 1 location
featured
Diabetes, Type 2

A research study is now underway in the Miami area and is seeking participants with Type 2 Diabetes that are currently being treated with only metformin and/or diet and exercise.  

  • 56 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of Ertugliflozin (MK 8835/PF 04971729) in the Treatment of Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin.

Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin.

  • 148 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III, Multicenter, Randomized, Double-Blind, Active-Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Ertugliflozin (MK-8835/PF-04971729) Compared With the Addition of Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

the Addition of Glimepiride in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

  • 84 views
  • 23 Nov, 2020
  • 1 location
featured
Type 2 Diabetes Study – Seeking Volunteers Who Treat with Any Combination of Medications, Except Insulin.

We are currently seeking volunteers who are diagnosed with Type 2 Diabetes and who are treating with any combination of medications including any of the following: Metformin

diabetes type 2
type 2 diabetes
diabetes mellitus (dm)
type 2 diabetes mellitus
diabetes mellitus
  • 0 views
  • 21 Jan, 2021